Detalhe da pesquisa
1.
Yellow fever neutralizing antibody seroprevalence proportion and titers in previously vaccinated adults with chronic kidney disease.
Vaccine
; 42(11): 2729-2732, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38514353
2.
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.
Diseases
; 12(1)2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38248380
3.
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.
Sci Rep
; 14(1): 7709, 2024 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565882
4.
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.
NPJ Vaccines
; 9(1): 54, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38459059
5.
Case report: Regression of Glioblastoma after flavivirus infection.
Front Med (Lausanne)
; 10: 1192070, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37324152
6.
Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose.
Vaccine
; 41(44): 6514-6528, 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37661534
7.
Yellow fever vaccination in Brazil: Short-term safety and immunogenicity in juvenile autoimmune rheumatic diseases.
Vaccine X
; 10: 100131, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34977552